My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search

Radico Khaitan Ltd Research Report - 08th Feb 2016

Miscellaneous | Published on Feb 06th 2016

IT

For 3QFY2016, Radico Khaitan (RKL) outperformed our estimates on the earnings front although the top-line came in flat yoy. On the operating front, the company reported margin expansion, primarily on account of lower raw material and selling & distribution expenses. Further, on the bottom-line front, the company reported a healthy growth due to strong operating performance and lower interest cost. Regular & others products segment de-grew which restricted overall top-line growth but healthy volume growth in Prestige & above products segment: For the quarter, RKL’s top-line grew flat yoy to ~Rs401cr (our estimate was of ~ Rs432cr), mainly due to the company’s shift in focus towards prestige and above products over higher volume mass market products. During the quarter, Prestige & above brands’ volume grew ~10.7% yoy. Prestige and above brands’ contribution to total Indian made foreign liquor (IMFL) volumes increased from 21.4% in 3QFY2015 to 24.6% in 3QFY2016. However, de-growth in Regular & others products segment which contribute more than 75% of total sales volume, restricted the overall top-line growth of the company. The company is continuously focusing on the high-margin Premium products segment to increase revenue. PAT grew ~19% yoy: The reported net profit for the quarter grew by 19% yoy to Rs25.4cr (our estimate was of Rs23.4cr) on account of strong operating performance and lower interest cost (in FY2015 the company has repaid a significant amount of its debt; further debt reduction is also on the cards). Outlook and valuation: RKL has not performed well in the last two years due to increasing material costs (ENA is a key raw material) and with it not receiving significant price hikes from various states. We expect the company to perform well going forward in anticipation of easing material costs and on expectation of better price hikes. This would result in an overall improvement in the operating margin of the company. Also, with the company having reduced significant debt from its balance sheet, it would be able to report an improvement in its profitability. We expect the company to report strong earnings CAGR of ~18% to ~Rs95cr over FY2015-17E. Hence, we recommend a Buy rating on the stock with a target price of Rs156.

Download Full Report

Accumulate

CMP 113
Target Price 156
Investment Period12 Months

Stock Info

MCAP BSE (Rs in Cr)1,590.61
MCAP NSE (Rs in Cr)1,589.28
P/E (x)18.95
EPS (Rs.)6.31
BV (Rs.)74.76
Div Yield (%)0.67
FV (Rs.)2.00
P/BV (x)1.60
EV/Sales (x)1.58
EV/EBITDA (x)12.89

Shareholding Pattern (%)

Promoter40.0
Public & Others25.0
Foreign21.0
Institution14.0
Corporate0.0
Grand Total100.0

Trade Securely

AngelEye

Portfolio Tracking & Trading Application View Demo